These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36591306)

  • 1. Efficacy and safety of neoadjuvant immunotherapy in resectable esophageal or gastroesophageal junction carcinoma: A pooled analysis of prospective clinical trials.
    Zhu J; Leng X; Gao B; Wang B; Zhang H; Wu L; Ma J; Tan Y; Peng L; Han Y; Wang Q
    Front Immunol; 2022; 13():1041233. PubMed ID: 36591306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable esophageal squamous cell carcinoma: A pooled analysis of randomized clinical trials.
    Yang Y; Shao R; Cao X; Chen M; Gong W; Ying H; Song G; You G; Qiu G; Chen Q; Ji Y; Xu D
    Radiother Oncol; 2024 Nov; 200():110517. PubMed ID: 39218039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid-term follow-up results of neoadjuvant sintilimab combined with chemotherapy for locally advanced resectable esophageal squamous cell carcinoma.
    Cai H; Chen L; Huang J; Ma H; Zhang S; Zhong K; Yang D; Sun J; Liu H; Song R
    Front Immunol; 2024; 15():1453176. PubMed ID: 39697347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neoadjuvant chemoradiotherapy versus neoadjuvant chemo-immunotherapy for locally advanced esophageal squamous cell carcinoma].
    Wang XY; Shen HX; Li RH; Wang JF; Fang M; Tao KY; Jiang YH; Ji YL
    Zhonghua Zhong Liu Za Zhi; 2024 Nov; 46(11):1058-1066. PubMed ID: 39622738
    [No Abstract]   [Full Text] [Related]  

  • 5. The short-term efficacy and safety of neoadjuvant Sintilimab combined with chemotherapy for resectable gastroesophageal junction adenocarcinoma.
    Chen L; Zhang S; Ma H; Zhong K; Yang D; Sun J; Liu H; Song R; Cai H
    Langenbecks Arch Surg; 2024 Dec; 410(1):5. PubMed ID: 39666161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral budesonide for induction of remission in ulcerative colitis.
    Sherlock ME; MacDonald JK; Griffiths AM; Steinhart AH; Seow CH
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007698. PubMed ID: 26497719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial.
    Liu SL; Li XY; Yang JH; Wen DX; Guo SS; Liu LT; Li YF; Luo MJ; Xie SY; Liang YJ; Sun XS; Yang ZC; Lv XF; Luo DH; Li JB; Liu Q; Wang P; Guo L; Mo HY; Sun R; Yang Q; Lan KQ; Jia GD; Li R; Zhao C; Xu RH; Chen QY; Tang LQ; Mai HQ
    Lancet Oncol; 2024 Dec; 25(12):1563-1575. PubMed ID: 39522541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant immunotherapy plus chemotherapy in high altitude natives with resectable esophageal squamous cell carcinoma in Tibet.
    Sui X; Danzeng D; Ni P; Geng J; Gesang P; Zhaxi R; Wei Y
    Asian J Surg; 2024 Dec; ():. PubMed ID: 39645490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes and Prognosis of Esophageal Squamous Cell Carcinoma Presenting with Obstruction.
    Ryu DG; Yu F; Liu H; Lee SS; Lee SL
    J Gastrointest Cancer; 2024 Dec; 56(1):35. PubMed ID: 39702624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative tislelizumab with four cycles of neoadjuvant chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: a phase 2 study.
    Zhou N; Hua Y; Ge Y; Wang Q; Wang C; He J; Zhao L; Yu S; Yan J; Zhao L; Li L; Bai C
    Front Immunol; 2024; 15():1482005. PubMed ID: 39687611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative tumor bed radiation versus T-shaped field radiation in the treatment of locally advanced thoracic esophageal squamous cell carcinoma: a phase IIb multicenter randomized controlled trial.
    Zeng Y; Li J; Ye J; Han G; Luo W; Wu C; Qin S; Gu W; Zhao S; Zhao Y; Xia B; Zhu Z; Du X; Liu Y; Liu J; Li H; Wang J; Guo J; Yu W; Zhang Q; Wang C; Fang W; Li Z; Fu X; Cai X
    BMC Med; 2024 Nov; 22(1):522. PubMed ID: 39511550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camrelizumab, chemotherapy and apatinib in the neoadjuvant treatment of resectable oesophageal squamous cell carcinoma: a single-arm phase 2 trial.
    Wu Z; Wu C; Zhao J; Wu C; Peng H; Wang Q; Bai R; Fang X; He H; Shen H; Wu M
    EClinicalMedicine; 2024 May; 71():102579. PubMed ID: 38618203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gordon M; Taylor K; Akobeng AK; Thomas AG
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX combined with tislelizumab and low-dose radiation therapy for the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase Ib/II clinical trial.
    Zhang PF; Chen Y; Li WK; Luo ZM; Chen J; Qian K; Chen XD; Wang MJ; Liu M
    Front Immunol; 2024; 15():1431957. PubMed ID: 39606219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagenase injection versus limited fasciectomy surgery to treat Dupuytren's contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation.
    Dias J; Tharmanathan P; Arundel C; Welch C; Wu Q; Leighton P; Armaou M; Corbacho B; Johnson N; James S; Cooke J; Bainbridge C; Craigen M; Warwick D; Brady S; Flett L; Jones J; Knowlson C; Watson M; Keding A; Hewitt C; Torgerson D
    Health Technol Assess; 2024 Dec; 28(78):1-262. PubMed ID: 39644138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant Dual Checkpoint Inhibitors vs Anti-PD1 Therapy in High-Risk Resectable Melanoma: A Pooled Analysis.
    Mangla A; Lee C; Mirsky MM; Wang M; Rothermel LD; Hoehn R; Bordeaux JS; Carroll BT; Theuner J; Li S; Fu P; Kirkwood JM
    JAMA Oncol; 2024 May; 10(5):612-620. PubMed ID: 38546551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.